Nasdaq
IMVT
Immunovant, Inc.
- Health Care
- Listed 2019
- 1 day
- +1.2%
- 1 month
- −0.9%
- 1 year
- +149%
$39.74 · Mkt cap $8.20B
At the 6 Aug 2026 close
Nasdaq
Immunovant, Inc.
$39.74 · Mkt cap $8.20B
At the 6 Aug 2026 close
Immunovant, Inc. trades under the ticker IMVT on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2019. Its market capitalisation is $8.20B. The last closing price was $39.74, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +149%, and −0.9% over the past month. Returns are price returns and exclude dividends.
This page exists because IMVT is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.